Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Celis

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigenHiroya Kobayashi, Ryusuke Omiya, Marta Ruiz, et al.
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
Hepatology (Baltimore, Md.)|February 15, 2018
Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapyWei Zhu, Yibing Peng, Lan Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2010
PRDM1/Blimp-1 controls effector cytokine production in human NK cellsMatthew A Smith, Michelle Maurin, Hyun Il Cho, et al.
Cancer Research|June 16, 2017
Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by <i>Ex Vivo</i> PI3K-δ InhibitionRasha Abu Eid, Shamim Ahmad, Yuan Lin, et al.
Oncoimmunology|December 5, 2018
Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinomaKenzo Ohara, Takayuki Ohkuri, Takumi Kumai, et al.
Oncoimmunology|July 30, 2016
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapyKei Ishibashi, Takumi Kumai, Takayuki Ohkuri, et al.
Nature Medicine|July 2, 2002
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasionHaidong Dong, Scott E Strome, Diva R Salomao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2014
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory AgentsShane Zaidi, Miran Blanchard, Kevin Shim, et al.
The Journal of Clinical Investigation|May 3, 2013
Lung tumor NF-κB signaling promotes T cell-mediated immune surveillanceEmily L Hopewell, Weipeng Zhao, William J Fulp, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigenHiroya Kobayashi, Ryusuke Omiya, Marta Ruiz, et al.
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
Hepatology (Baltimore, Md.)|February 15, 2018
Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapyWei Zhu, Yibing Peng, Lan Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2010
PRDM1/Blimp-1 controls effector cytokine production in human NK cellsMatthew A Smith, Michelle Maurin, Hyun Il Cho, et al.
Cancer Research|June 16, 2017
Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by <i>Ex Vivo</i> PI3K-δ InhibitionRasha Abu Eid, Shamim Ahmad, Yuan Lin, et al.
Oncoimmunology|December 5, 2018
Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinomaKenzo Ohara, Takayuki Ohkuri, Takumi Kumai, et al.
Oncoimmunology|July 30, 2016
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapyKei Ishibashi, Takumi Kumai, Takayuki Ohkuri, et al.
Nature Medicine|July 2, 2002
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasionHaidong Dong, Scott E Strome, Diva R Salomao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2014
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory AgentsShane Zaidi, Miran Blanchard, Kevin Shim, et al.
The Journal of Clinical Investigation|May 3, 2013
Lung tumor NF-κB signaling promotes T cell-mediated immune surveillanceEmily L Hopewell, Weipeng Zhao, William J Fulp, et al.
Pageof 13